Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells.[1][2]
Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS.
External links
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.